Gufic BioSciences Intrinsic Value
Gufic BioSciences (GUFICBIO) median intrinsic value is ₹577.40 from 8 valuation models (range ₹87–₹722), vs current price ₹288.70 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Browse GUFICBIO balance sheet details for revenue, profit, balance sheet and cash flow data.
GUFICBIO Valuation Methods Summary — DCF, Graham Number & P/E
Gufic BioSciences intrinsic value across 8 models vs current price ₹288.70 — upside/downside and value range per method. For current market price and key ratios, visit Gufic BioSciences share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹147.84 | ₹118.27 - ₹177.41 | -48.8% | EPS: ₹6.72, Sector P/E: 22x |
| Book Value Method | asset | ₹721.75 | ₹649.58 - ₹793.93 | +150.0% | Book Value/Share: ₹601.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹577.40 | ₹519.66 - ₹635.14 | +100.0% | Revenue/Share: ₹956.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹577.40 | ₹519.66 - ₹635.14 | +100.0% | EBITDA: ₹160.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹86.61 | ₹77.95 - ₹95.27 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹103.82 | ₹93.44 - ₹114.20 | -64.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹577.40 | ₹519.66 - ₹635.14 | +100.0% | ROE: 11.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹301.45 | ₹271.31 - ₹331.60 | +4.4% | EPS: ₹6.72, BVPS: ₹601.00 |
GUFICBIO Intrinsic Value vs Market Price — All Valuation Models
Gufic BioSciences fair value range ₹87–₹722 vs current market price ₹288.70 across 8 valuation models. Also explore GUFICBIO price trends to track price trends across different timeframes.
GUFICBIO Intrinsic Value Analysis — Undervalued or Overvalued?
Gufic BioSciences median intrinsic value ₹577.40, current price ₹288.70 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of GUFICBIO?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Gufic BioSciences (GUFICBIO) is ₹577.40 (median value). With the current market price of ₹288.70, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹86.61 to ₹721.75, indicating ₹86.61 - ₹721.75.
Is GUFICBIO undervalued or overvalued?
Based on our multi-method analysis, Gufic BioSciences (GUFICBIO) appears to be trading below calculated value by approximately 100.0%.
GUFICBIO Financial Health — Key Ratios vs Industry Benchmarks
Gufic BioSciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.45 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 11.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.82x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
GUFICBIO Cash Flow Quality — Operating & Free Cash Flow
Gufic BioSciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹123 Cr | ₹88 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-8 Cr | ₹-59 Cr | Negative Cash Flow | 3/10 |